Melatonin (N-acetyl-5-methoxytryptamine) is a chemical mediator produc
ed in the pineal gland and other sites in the body. The melatonin foun
d in the blood is derived almost exclusively from the pineal gland. Si
nce the pineal synthesizes melatonin primarily at night, blood levels
of the indole are also higher at night (5-15 fold) than during the day
. Some individuals on a nightly basis produce twice as much melatonin
as others of the same age. Throughout life, the melatonin rhythm gradu
ally wanes such that, in advanced age, melatonin production is usually
at a minimum. Melatonin was recently found to be a free radical scave
nger and antioxidant. It has been shown, in the experimental setting,
to protect against both free radical induced DNA damage and oxidative
stress-mediated lipid peroxidation. Pharmacologically, melatonin has b
een shown to reduce oxidative damage caused by such toxins as the chem
ical carcinogen safrole, carbon tetrachloride, paraquat, bacterial lip
opolysaccharide, kainic acid, delta-aminolevulinic and amyloid beta pe
ptide of Alzheimer's disease as well as a model of Parkinson's disease
involving the drug 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP
). Additionally, the oxidative damage caused by agents such as ionizin
g radiation and excessive exercise is reduced by melatonin. Since free
radical-induced molecular injury may play a significant role in aging
, melatonin's ability to protect against it suggests a potential funct
ion of melatonin in deferring aging and age-related, free radical-base
d diseases. Besides its ability to abate oxidative damage, other benef
icial features of melatonin may be important in combating the signs of
aging; these include melatonin's immune-stimulating function, its sle
ep-promoting ability, its function as an anti-viral agent, and general
protective actions at the cellular level. Definitive tests of the spe
cific functions of physiological levels of melatonin in processes of a
ging are currently being conducted.